Maze Therapeutics (MAZE) Stock Chart & Stock Price History $15.25 +0.35 (+2.35%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Maze Therapeutics Stock Price Performance The Maze Therapeutics (MAZE) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 32.61%, reflecting recent market activity. As of the latest close, Maze Therapeutics traded at $14.90 with a market cap of $652.58 million and volume of 243,255 shares. Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.61%1 Month Performance+32.61%3 Month Performance+40.55% MAZE Stock Chart for Monday, August, 4, 2025 MAZE Chart by TradingView Maze Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$14.75$14.90+1.02%$15.38$13.82243,255 shs$652.58 million07/31/2025$15.50$14.75-4.84%$15.68$14.20270,005 shs$646.05 million07/30/2025$15.74$15.50-1.52%$16.54$15.30114,700 shs$678.90 million07/29/2025$16.36$15.74-3.79%$16.48$15.00117,838 shs$689.37 million07/28/2025$16.82$16.36-2.73%$17.38$16.1846,422 shs$716.57 million07/25/2025$16.45$16.82+2.25%$17.10$16.1451,167 shs$736.72 million07/24/2025$17.64$16.45-6.75%$18.40$16.1185,863 shs$720.51 million07/23/2025$16.94$17.64+4.13%$19.19$17.01331,515 shs$772.58 million07/22/2025$16.66$16.94+1.68%$17.19$15.17130,062 shs$741.97 million07/21/2025$17.78$16.66-6.30%$18.67$16.11297,388 shs$729.71 million Get the Latest News and Ratings for MAZE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$17.06$17.78+4.22%$18.50$16.80113,342 shs$778.76 million07/17/2025$16.26$17.06+4.92%$17.41$16.12130,376 shs$747.18 million07/16/2025$16.01$16.26+1.56%$16.69$15.87122,198 shs$712.19 million07/15/2025$15.74$16.01+1.72%$16.20$14.8989,289 shs$701.24 million07/14/2025$15.05$15.74+4.58%$15.86$14.3571,598 shs$689.41 million07/11/2025$15.64$15.05-3.77%$15.84$14.91127,024 shs$659.19 million07/10/2025$15.08$15.64+3.71%$15.75$14.5387,682 shs$684.99 million07/09/2025$15.06$15.08+0.13%$15.42$14.00200,292 shs$660.50 million07/08/2025$12.12$15.06+24.26%$15.79$12.44253,159 shs$659.63 million07/07/2025$11.50$12.12+5.39%$12.20$11.34105,666 shs$530.82 million07/04/2025$11.50$11.50$12.44$10.9878,157 shs$503.70 million07/03/2025$11.86$11.50-3.04%$12.44$10.9878,157 shs$503.67 million Related Companies MorphoSys Stock Chart Crinetics Pharmaceuticals Stock Chart Alvotech Stock Chart Organon & Co. Stock Chart Recursion Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart NewAmsterdam Pharma Stock Chart Mirum Pharmaceuticals Stock Chart Ultragenyx Pharmaceutical Stock Chart Catalyst Pharmaceuticals Stock Chart Receive MAZE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Maze Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MAZE) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maze Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maze Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MAZE Stock Alerts